Stock Events

Stock Events

Enliven Therapeutics (ELVN) Q1 2026 Earnings

3MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.57

-0.49

-0.4

-0.32

Details

Expected EPS

-0.385

Actual EPS

-0.48

Surprise EPS

-0.09

Surprise Percent

+24.68%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.48 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.